Bioventus Inc. (44)

Browse by Contract Category

Contracts

Employment Agreement, dated February 14, 2022, between the Company and Mark Singleton (Filed With SEC on February 28, 2022)
Lease Agreement, dated November 17, 2021, between Bioventus LLC and 7101 Goodlett Farms Parkway, LLC (Filed With SEC on November 22, 2021)
Amendment No. 1 to Cre (Filed With SEC on November 10, 2021)
Agreement and Plan of Merger, dated as of July 29, 2021, by and among Bioventus Inc., Oyster Merger Sub I, Inc., Oyster Merger Sub II, LLC and Misonix, Inc (Filed With SEC on July 29, 2021)
Agreement and plan of merger, dated as of March 30, 2021, by and among Bioventus LLC, Bioness Inc., Perseus Intermediate, Inc., Perseus Merger Sub, Inc., Alfred E. Mann Living... (Filed With SEC on March 31, 2021)
Settlement Agreement, dated as of February 22, 2021, by and between the United States of America, acting through the United States Attorneys Office for the Middle District of... (Filed With SEC on March 26, 2021)
Second Amended and Restated Limited Liability Company Agreement of Bioventus LLC, dated as of February 16, 2021 (Filed With SEC on February 17, 2021)
Amendment No. 2 to Exclusive License, Supply and Distribution Agreement, dated as of December 31, 2020, by and between IBSA Institut Biochimique SA (Switzerland) and Bioventus LLC (Filed With SEC on February 4, 2021)
Description of Securities (Filed With SEC on March 26, 2021)
Tax Receivable Agreement, dated as of February 16, 2021, by and among Bioventus Inc., Bioventus LLC and its Members (Filed With SEC on February 17, 2021)
Registration Rights Agreement, dated February 16, 2021, by and among Bioventus Inc. and the Original LLC Owners (Filed With SEC on February 17, 2021)
Stockholders Agreement, dated February 16, 2021, by and among Bioventus Inc., Bioventus LLC and the Principal Stockholders (Filed With SEC on February 17, 2021)
Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Agreement (Filed With SEC on February 10, 2021)
Option Forfeiture Letter, dated February 3, 2021, by and between Bioventus LLC and Kenneth Reali (Filed With SEC on February 10, 2021)
Employment Agreement, dated February 9, 2021, by and among Bioventus Inc., Bioventus LLC and Alessandra Pavesio (Filed With SEC on February 10, 2021)
Employment Agreement, dated February 9, 2021, by and among Bioventus Inc., Bioventus LLC and Anthony DAdamio (Filed With SEC on February 10, 2021)
Employment Agreement, dated February 9, 2021, by and among Bioventus Inc., Bioventus LLC and John E. Nosenzo (Filed With SEC on February 10, 2021)
Employment Agreement, dated February 9, 2021, by and among Bioventus Inc., Bioventus LLC and Gregory O. Anglum (Filed With SEC on February 10, 2021)
Employment Agreement, dated February 9, 2021, by and among Bioventus Inc., Bioventus LLC and Kenneth Reali (Filed With SEC on February 10, 2021)
Bioventus Inc. Non-Employee Director Compensation Policy (Filed With SEC on February 10, 2021)
Assignment and Assumption Agreement, dated February 9, 2021, by and between Bioventus Inc. and Bioventus LLC (Filed With SEC on February 10, 2021)
Amendment and Termination of the Bioventus Stock Plan, dated as of February 9, 2021 (Filed With SEC on February 10, 2021)
Form of Stock Option Award Grant Notice and Stock Option Agreement (Filed With SEC on February 10, 2021)
Form of Stockholders Agreement, to be effective upon the closing of this offering (Filed With SEC on February 10, 2021)
Form of Second Amended and Restated Bioventus LLC Limited Liability Company Agreement, to be effective upon the closing of this offering (Filed With SEC on February 10, 2021)
Form of Registration Rights Agreement, to be effective upon the closing of this offering (Filed With SEC on February 10, 2021)
Form of 2021 Incentive Award Plan (Filed With SEC on February 10, 2021)
Form of Second Amended and Restated Bioventus LLC Limited Liability Company Agreement, to be effective upon the closing of this offering (Filed With SEC on February 4, 2021)
Form of Underwriting Agreement (Filed With SEC on February 4, 2021)
Form of Tax Receivable Agreement, to be effective upon the closing of this offering (Filed With SEC on February 4, 2021)
Form of Registration Rights Agreement, to be effective upon the closing of this offering (Filed With SEC on February 4, 2021)
Bioventus LLC Management Incentive Plan (Filed With SEC on February 4, 2021)
Form of Stockholders Agreement, to be effective upon the closing of this offering (Filed With SEC on February 4, 2021)
Form of 2021 Employee Stock Purchase Plan (Filed With SEC on February 4, 2021)
Form of 2021 Incentive Award Plan (Filed With SEC on February 4, 2021)
Form of Indemnification Agreement (Filed With SEC on February 4, 2021)
Exclusive License, Supply and Distribution Agreement, dated as of February 9, 2016, by and between IBSA Institut Biochimique SA (Switzerland) and Bioventus LLC (Filed With SEC on January 20, 2021)
Amended and Restated License Agreement, dated as of December 9, 2016, by and between Bioventus LLC, Q-Med AB and Nestl Skin Health S.A (Filed With SEC on January 20, 2021)
Amended and Restated Supply Agreement, dated as of December 9, 2016, by and between Bioventus LLC and Q-Med AB (Filed With SEC on January 20, 2021)
Amended and Restated Limited Liability Company Agreement of Bioventus LLC, as amended, as currently in effect (Filed With SEC on January 20, 2021)
Amendment No. 1 to Exclusive License, Supply and Distribution Agreement, dated as of December 31, 2018, by and between IBSA Institut Biochimique SA (Switzerland) and Bioventus LLC (Filed With SEC on January 20, 2021)
Amended and Restated Exclusive Distribution Agreement No. 2 by and between Seikagaku Corporation and Bioventus LLC, effective December 22, 2020 (Filed With SEC on January 20, 2021)
Option and Equity Purchase Agreement, dated as of July 15, 2020, among Bioventus LLC, CartiHeal (2009) Ltd., the Securityholders set forth on Schedule 1.01(a) thereto, each of the... (Filed With SEC on January 20, 2021)
Specimen Stock Certificate evidencing the shares of Class A common stock (Filed With SEC on January 20, 2021)